U.S. Securities & Exchange Commission v. Citigroup Global Markets Inc.

827 F. Supp. 2d 328, 2011 U.S. Dist. LEXIS 135914
District Court, S.D. New York·Decided November 28, 2011·No. No. 11 Civ. 7387 (JSR)·Published·Cited by 16 cases

Opinion

OPINION AND ORDER

JED S. RAKOFF, District Judge.

On October 19, 2011, the U.S. Securities and Exchange Commission (the “S.E.C.”) filed this lawsuit, accusing defendant Citigroup Global Markets Inc. (“Citigroup”) of a substantial securities fraud. According to the S.E.C.’s Complaint, after Citigroup realized in early 2007 that the market for mortgage-backed securities was beginning to weaken, Citigroup created a billion-dollar Fund (known as “Class V Funding III”) that allowed it to dump some dubious assets on misinformed investors. This was accomplished by Citigroup’s misrepresenting that the Fund’s assets were attractive investments rigorously selected by an independent investment adviser, whereas in fact Citigroup had arranged to include in the portfolio a substantial percentage of negatively projected assets and had then taken a short position in those very assets it had helped select. Complaint ¶¶ 1, 2, 58. Having structured the Fund as a vehicle for unloading these dubious assets on unwitting investors, id. ¶ 44, Citigroup realized net profits of around $160 million, id. ¶ 63, whereas the investors, as the S.E.C. later revealed, lost more than $700 million. See S.E.C.’s Memorandum of Law in Response to Questions Posed by the Court Regarding Proposed Settlement (“SEC Mem.”) at 17.

In a parallel Complaint filed the same day against Citigroup employee Brian Stoker, see U.S. Securities and Exchange Commission v. Brian H. Stoker; 11 Civ. 7388MSR),1 the S.E.C. alleged that Citi[330] group knew in advance that it would be difficult to sell the Fund if Citigroup disclosed its intention to use it as a vehicle to unload its hand-picked set of negatively projected assets, see Stoker Complaint ¶25. Specifically, paragraph 25 of the Stoker Complaint alleges (in language some of which is notably missing from the Citigroup Complaint) that:

Citigroup knew it would be difficult to place the liabilities of [the Fund] if it disclosed to investors its intention to use the vehicle to short a hand-picked set of [poorly rated assets].... By contrast, Citigroup knew that representing to investors that an experienced third-party investment adviser had selected the portfolio would facilitate the placement of the [Fund’s] liabilities, (emphasis supplied)

Although this would appear to be tantamount to an allegation of knowing and fraudulent intent (“scienter,” in the lingo of securities law), the S.E.C., for reasons of its own, chose to charge Citigroup only with negligence, in violation of Sections 17(a)(2) and (3) of the Securities Act, 15 U.S.C. § 77q(a)(2) and (3). Complaint ¶ 65.

Simultaneously with the filing of its Complaint against Citigroup, the S.E.C. presented to the Court for its signature a “Final Judgment As To Defendant Citigroup Global Markets Inc.” (the “Consent Judgment”), together with a Consent of Defendant Citigroup Global Markets Inc. (the “Consent”) that recited that Citigroup consented to the entry of the Consent Judgment “[w]ithout admitting or denying the allegations of the complaint....” Consent ¶ 2. The Consent Judgment (I) “permanently restrained and enjoined” Citigroup and its agents, employees, etc., from future violations of Sections 17(a)(2) and (3) of the Securities Act, (II) required Citigroup to disgorge to the S.E.C. Citigroup’s $160 million in profits, plus $30 million in interest thereon, and to pay to the S.E.C. a civil penalty in the amount of $95 million, and (III) required Citigroup to undertake for a period of three years, subject to enforcement by the Court, certain internal measures designed to prevent recurrences of the securities fraud here perpetrated.

Upon receipt of these submissions, the Court, by Order dated October 27, 2011, put some questions to the parties concerning the proposed Consent Judgment, to which the parties responded both in writing, see SEC Mem., supra, and Memorandum on Behalf of Citigroup Global Markets Inc. in Support of the Proposed Final Judgment and Consent (“Citigroup Mem.”), and orally, see transcript of oral argument, 11/9/11 (“Tr.”). Since then, the Court has spent long hours trying to determine whether, in view of the substantial deference due the S.E.C. in matters of this kind, the Court can somehow approve this problematic Consent Judgment. In the end, the Court concludes that it cannot approve it, because the Court has not been provided with any proven or admitted facts upon which to exercise even a modest degree of independent judgment.

The Court turns first to the standard of review. In its original Memorandum in support of the proposed Consent Judgment, filed before the ease had been assigned to any judge, the S.E.C. expressly endorsed the standard of review set forth by this Court in its Bank of America decisions, ie., “whether the proposed Consent Judgment ... is fair, reasonable, adequate, and in the public interest.” Memorandum By Plaintiff Securities and Exchange Commission in Support of Proposed Settlement at 5 (quoting with approval SEC v. Bank of America Corp., 653 F.Supp.2d 507, 508 (S.D.N.Y.2009) (“Bank of America I”)); see also SEC v. Bank of America Corp., 2010 WL 624581, [331] at *6 (S.D.N.Y. Feb. 22, 2010) (“Bank of America II”). This was also the SJE.C.’s stated position in another, intervening proceeding before this Court, SEC v. Vitesse Semiconductor Corp., 771 F.Supp.2d 304 (S.D.N.Y.2011).

Free access — add to your briefcase to read the full text and ask questions with AI

U.S. Securities & Exchange Commission v. Citigroup Global Markets Inc., 827 F. Supp. 2d 328, 2011 U.S. Dist. LEXIS 135914 (S.D.N.Y. 2011).

827 F. Supp. 2d 328 (U.S. Securities & Exchange Commission v. Citigroup Global Markets Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Aegerion Pharmaceuticals, Inc.
280 F. Supp. 3d 217 (D. Massachusetts, 2017)
People v. Greenberg
127 A.D.3d 529 (Appellate Division of the Supreme Court of New York, 2015)
In re Nexium
968 F. Supp. 2d 367 (D. Massachusetts, 2013)
United States v. Orthofix, Inc.
956 F. Supp. 2d 316 (D. Massachusetts, 2013)
United States v. Stanley
881 F. Supp. 2d 563 (S.D. New York, 2012)
Securities & Exchange Commission v. Cioffi
868 F. Supp. 2d 65 (E.D. New York, 2012)
LSSI Data Corp. v. Time Warner Cable, Inc.
892 F. Supp. 2d 489 (S.D. New York, 2012)